Grafton Hunt Thurman, MD | |
3443 Dickerson Pike, Suite 512, Nashville, TN 37207-2520 | |
(615) 868-3553 | |
(615) 612-3106 |
Full Name | Grafton Hunt Thurman |
---|---|
Gender | Male |
Speciality | Internal Medicine - Rheumatology |
Location | 3443 Dickerson Pike, Nashville, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013955707 | NPI | - | NPPES |
3704507 | Medicaid | TN | |
015222 | Other | TN | BLUE CROSS BLUE SHIELD |
Mailing Address | Practice Location Address |
---|---|
Grafton Hunt Thurman, MD 3443 Dickerson Pike, Suite 512, Nashville, TN 37207-2520 Ph: (615) 868-3553 | Grafton Hunt Thurman, MD 3443 Dickerson Pike, Suite 512, Nashville, TN 37207-2520 Ph: (615) 868-3553 |
News Archive
Antibacterial wipes which have become increasingly popular in many homes, nursing homes, schools and hospitals, may not it seems be the answer when it comes to getting rid of dangerous bacteria.
Analyses of cell signals provide insight into the origin of severe inflammatory symptoms that appear in various types of blood cancer and point to possible therapeutic approaches: In around one-fourth of patients suffering from juvenile myelomonocytic leukemia, there is evidence of mutations in the so-called KRAS gene in the leukemia cells.
More than 300 scientific studies point to an antioxidant found in broccoli sprouts, sulforaphane glucosinolate (SGS), as a factor in preventing multiple diseases, including several types of cancer, high blood pressure, macular degeneration and stomach ulcers.
U.S. drug reviewers might limit the use of a Seattle Genetics Inc's experimental blood cancer drug due to the narrow scope of its clinical trials. According to papers released Tuesday by the Food and Drug Administration (FDA), it requests an advisory panel to consider the drug, under the proposed trade name Adcetris known chemically as brentuximab vedotin, for use in previously treated patients with Hodgkin's lymphoma and anaplastic large cell lymphoma (ALCL).
Dutch researchers of the Radboud University Medical Center in Nijmegen found a new gene for Sensenbrenner syndrome (Journal of Medical Genetics, 2011 Mar 4). The mutation adds support to the hypothesis that defects in ciliar transport are the cause of the disease. Project leader Dr. Heleen H. Arts is supported by a Kolff Junior Postdoc Grant of the Dutch Kidney Foundation.
› Verified 9 days ago
Megan Desai, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Rheumatology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Dr. Evan Zehr, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1161 21st Ave S, Nashville, TN 37232 Phone: 615-322-6943 | |
Spurthi N Bhatt, MD MPH Rheumatology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 |